---
figid: PMC8924093__10555_2022_10021_Fig3_HTML
figtitle: 'Anti-HER2 therapy in metastatic breast cancer: many choices and future
  directions'
organisms:
- Homo sapiens
- Mus musculus
- Adolphia infesta
pmcid: PMC8924093
filename: 10555_2022_10021_Fig3_HTML.jpg
figlink: /pmc/articles/PMC8924093/figure/Fig3/
number: F3
caption: Pathways of resistance to anti-HER2 therapies, including p95. Important pathways
  involved in anti-HER2 resistance such as the PI3K/AKT/mTOR pathway and the expression
  of HER2 p95 lacking the extracellular trastuzumab-binding domain
papertitle: 'Anti-HER2 therapy in metastatic breast cancer: many choices and future
  directions.'
reftext: Carrie S. Wynn, et al. Cancer Metastasis Rev. 2022;41(1):193-209.
year: '2022'
doi: 10.1007/s10555-022-10021-x
journal_title: Cancer Metastasis Reviews
journal_nlm_ta: Cancer Metastasis Rev
publisher_name: Springer US
keywords: Anti-HER2 therapy | HER2 + metastatic breast cancer | Treatment | Drug resistance
  | New drugs
automl_pathway: 0.9368524
figid_alias: PMC8924093__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8924093__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8924093__10555_2022_10021_Fig3_HTML.html
  '@type': Dataset
  description: Pathways of resistance to anti-HER2 therapies, including p95. Important
    pathways involved in anti-HER2 resistance such as the PI3K/AKT/mTOR pathway and
    the expression of HER2 p95 lacking the extracellular trastuzumab-binding domain
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Erbb3
  - Egfr
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Mdk
  - Igf1
  - Pik3r1
  - Akt1
  - Mtor
  - di
  - Cdk6
  - Cdk4
  - Pten
  - Ccnd1
  - Erbb2
  - ERBB3
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IGF1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - CDK6
  - CDK4
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK5
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PTEN
  - CCND1
  - ERBB2
  - NBN
---
